Abstract: A ferroelectric chiral smectic liquid crystal composition, comprising at least one compound represented by the following formula (I): ##STR1## wherein R.sub.1 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent, R.sub.2 denotes a linear or branched alkyl group having 1-14 carbon atoms capable of having a substituent; X.sub.1 and X.sub.2 respectively denote a single bond, ##STR2## m is 0-7; and n is 0 or 1; and at least one compound represented by the following formula (II): ##STR3## wherein R.sub.3 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; R.sub.4 denotes a linear alkyl group having 1-10 carbon atoms; X.sub.

Abstract: Disclosed is a method for separating a blood material into leukocyte-removed blood component products, which comprises providing a multiple blood bag system comprising a primary bag containing a blood material, a leukocyte-removing filter device comprising a flat casing, and at least one satellite bag, and centrifuging the blood material using a centrifuge cup having the multiple blood bag system accommodated therein, to thereby separate the blood material into blood components, wherein the centrifugation is performed with the filter device being held by a filter device holder having a substantially flat dimension which is disposed in a centrifuge cup so as to extend in a direction perpendicular to an inner bottom floor of the centrifuge cup, and wherein the filter device holder has a recess and the filter device is received by the recess in a manner such that a flat surface of the flat casing of the filter device is perpendicular to the inner bottom floor of the centrifuge cup.

Abstract: A ferroelectric chiral smectic liquid crystal composition, comprising at least one compound represented by the following formula (I): ##STR1## wherein R.sub.1 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent, R.sub.2 denotes a linear or branched alkyl group having 1-14 carbon atoms capable of having a substituent; X.sub.1 and X.sub.2 respectively denote a single bond, --O--, ##STR2## m is 0-7; and n is 0 or 1; and at least one compound represented by the following formula (II): ##STR3## wherein R.sub.3 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; R.sub.4 denotes a linear alkyl group having 1-10 carbon atoms; X.sub.3 denotes a single bond, --O--, ##STR4## Y denotes ##STR5## --CH.sub.2 O-- or --OCH.sub.

Abstract: A ferroelectric chiral smectic liquid crystal composition, comprising at least one compound represented by the following formula (I): ##STR1## wherein R.sub.1 and R.sub.2 respectively denote a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; X.sub.1 and X.sub.2 respectively denote a single bond, --O--, ##STR2## Y.sub.1 denotes --CH.sub.2 O-- or --OCH.sub.2 --; and m and n are respectively 1 or 2; and at least one compound represented by the following formula (II): ##STR3## wherein R.sub.3 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; X.sub.3 denotes a single bond, --O-- or ##STR4## Z denotes a single bond or ##STR5## and p is an integer of 1-12.

Abstract: A liquid crystal display device is provided with a pair of mutually opposed transparent substrates, a pair of groups of transparent stripe electrode formed respectively on the internal faces of the substrates in mutually crossing manner, and liquid crystal positioned between the groups of stripe electrodes. The groups of stripe electrodes are provided respectively with opaque metal members for reducing the electrical resistance of the stripe electrodes. The opaque metal members are so formed as not to mutually overlap and as to complementarily constitute light shields in non-display areas.

Abstract: A ferroelectric chiral smectic liquid crystal composition, comprising: at least one optically active compound represented by the following formula (II): ##STR1## wherein R.sub.3 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; X.sub.3 denotes a single bond, ##STR2## Z.sub.1 denotes a single bond or ##STR3## and m is 1-12; at least one compound represented by the following formula (III): ##STR4## wherein R.sub.4 and R.sub.5 respectively denote a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent, at lease one of R.sub.4 and R.sub.5 being optically active; X.sub.4 denotes a single bond, ##STR5## and X.sub.5 denotes a single bond, ##STR6## and at least one compound represented by the following formula (I) or (IV): ##STR7## wherein R.sub.1 and R.sub.2 respectively denote a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent of C.sub.1 -C.sub.12 alkoxy group; X.sub.1 and X.sub.

Abstract: A ferroelectric chiral smectic liquid crystal composition, comprising at least one compound represented by the following formula (I): ##STR1## wherein R.sub.1 denotes a linear or branched alkyl group having 1-18 carbon atoms capable of having a substituent; R.sub.2 denotes a linear or branched alkyl group having 1-14 carbon atoms capable of having a substituent; X.sub.1 and X.sub.2 respectively denote a single bond, --O--, ##STR2## m is 0-7; and n is 0 or 1; and at least one compound represented by the following formula (II): ##STR3## wherein R.sub.3 and R.sub.4 respectively denote a linear alkyl group having 1-18 carbon atoms and one --CH.sub.2 -- not bonded to X.sub.4 in the alkyl group can be replaced with --O--; X.sub.3 and X.sub.4 respectively denote a single bond, --O--, ##STR4## and p and q are respectively 0, 1 or 2 with proviso that both of p and q are not 0.

Abstract: A mesomorphic liquid crystal composition stably exhibits lowered resistivity for quickly attenuating a reverse voltage caused by charge localization.